Roya Vahedi-Shahandashti

9PUBLICATIONS
11CO-AUTHORS
Medical infection agents (incl. prions)Medical virologyMedical mycologyMedical bacteriologyBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 10, 2026
Why intrinsic reduced susceptibility in rare fungal pathogens should be differentiated from intrinsic resistance: an ISHAM conceptual framework and narrative review.

|May 15, 2026
Can voriconazole gradient diffusion testing results be extrapolated to isavuconazole and posaconazole in Aspergillus spp.? Comparative analysis with CLSI broth microdilution and cyp51A gene sequencing.

|Nov 10, 2025
Diagnostic Performance of a PCR-Based Approach for the Diagnosis of Dermatomycosis.

Stephan Steixner, Stefan Fuchs, Roya Vahedi-Shahandashti

|Aug 06, 2025
Diagnostic Value of Microscopy, Galactomannan, and PCR in Aspergillus Culture-Positive BALF Samples: A Laboratory-Based Pilot Study.

Miriam Govrins, Roya Vahedi-Shahandashti, Cornelia Lass-Flörl

|Jul 01, 2025
Candida parapsilosis and echinocandins: should the clinical laboratory drop anidulafungin Etest from the susceptibility testing panel?

Roya Vahedi-Shahandashti, Eleonora Moroder, Cornelia Lass-Flörl

|Jun 17, 2025
The impact of respiratory tract mimicking media on antifungal susceptibility testing.

Roya Vahedi-Shahandashti, Isabella Hofer, Hollie Leighton

Pageof 2

Frequent Collaborators

9 joint publications

Cornelia Lass-Flörl

2 joint publications

David Eisele

2 joint publications

Ferry Hagen

2 joint publications

Stephan Steixner